1-3 of 3
James Lynch
Close
Sort by
Journal Articles

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Karen E. Deffenbacher, Javeed Iqbal, Warren Sanger, Yulei Shen, Cynthia Lachel, Zhongfeng Liu, Yanyan Liu, Megan S. Lim, Sherrie L. Perkins, Kai Fu, Lynette Smith, James Lynch, Louis M. Staudt, Lisa M. Rimsza, Elaine Jaffe, Andreas Rosenwald, German K. Ott, Jan Delabie, Elias Campo, Randy D. Gascoyne, Mitchell S. Cairo, Dennis D. Weisenburger, Timothy C. Greiner, Thomas G. Gross, Wing C. Chan
Journal: Blood
Blood (2012) 119 (16): 3757–3766.
https://doi.org/10.1182/blood-2011-05-349662
Published: 2012
Includes: Supplemental data
Journal Articles

Preliminary Results of the Addition of Rasburicase to the Reduction Cycle and Rituximab to the Induction and Consolidation Cycles of FAB Group C Chemotherapy in Children and Adolescents with Advanced Stage (Bone Marrow ±CNS) Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report.

Stanton Goldman, MD, James Lynch, PhD, Lauren Harrison, RN, Thomas Gross, MD, PhD, Bruce Shiramizu, MD, Warren Sanger, PhD, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2009) 114 (22): 104.
https://doi.org/10.1182/blood.V114.22.104.104
Published: 2009
Journal Articles

Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab + FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children’s Oncology Group Report

Mitchell S. Cairo, MD, James Lynch, PhD, Lauren Harrison, RN, Carmella van de Ven, MS, Thomas Gross, MD, PhD, Bruce Shiramizu, MD, Warren Sanger, PhD, Sherrie L. Perkins, MD, PhD, Stanton Goldman, MD
Journal: Blood
Blood (2008) 112 (11): 838.
https://doi.org/10.1182/blood.V112.11.838.838
Published: 2008